首页> 外文期刊>Neuroepidemiology >Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials
【24h】

Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials

机译:复发-缓解型多发性硬化症中持续残疾进展与功能系统评分之间的关​​系:来自四个随机临床试验的安慰剂数据分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The Expanded Disability Status Scale (EDSS), based on different functional system scores (FSS), remains the most frequently used disability assessment in relapsing-remitting multiple sclerosis (RRMS). In this analysis, we evaluated the relationship between sustained disability progression, measured by EDSS, and simultaneous changes in individual FSS domains. Methods: A post hoc analysis was performed on data from placebo-treated RRMS patients from four large, randomized, multicenter, phase 3 clinical trials. Sustained disability progression was defined as a EDSS score increase over a or >= 3- or >= 6-month period. Simultaneous sustained disability progression and worsening of individual FSS domains was analyzed. Results: The majority of patients experienced sustained disability progression and simultaneous worsening of FSS domain, with >= 1-point worsening in the pyramidal domain being most frequently associated with sustained disability progression (in 31-51% of patients), followed by 1-point worsening in the cerebellar (35-41% of patients) and sensory (31-45% of patients) domains. Conclusion: The key FSS components correlating with sustained disability progression, measured by EDSS, appear to be pyramidal, cerebellar, and sensory. In this analysis, the simultaneous worsening of consistent FSS domains confirms the validity and reliability of the use of sustained EDSS progression as a measure of disability progression. (C) 2015 S. Karger AG, Basel
机译:背景:基于不同功能系统评分(FSS)的扩展残疾状况量表(EDSS)仍然是复发-释放性多发性硬化症(RRMS)中最常用的残疾评估。在此分析中,我们评估了由EDSS衡量的持续残疾进展与各个FSS域中同时发生的变化之间的关系。方法:对来自四个大型,随机,多中心,3期临床试验的安慰剂治疗的RRMS患者的数据进行事后分析。持续残疾进展定义为EDSS评分在3个月或≥3个月或≥6个月内增加。分析了同时持续的残疾进展和单个FSS域的恶化。结果:大多数患者经历了持续的残疾进展并同时出现FSS域恶​​化,其中锥体区域恶化> = 1点最常与持续的残疾进展相关(在31-51%的患者中),然后是1-小脑(占患者的35-41%)和感官(占患者的31-45%)领域的症状恶化。结论:通过EDSS测量,与持续残疾进展相关的FSS关键成分似乎是锥体,小脑和感觉。在此分析中,一致的FSS域的同时恶化证实了使用持续EDSS进展作为残疾进展测量的有效性和可靠性。 (C)2015 S.Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号